stockrowCapricor Therapeutics, Inc. (CAPR) vs MiMedx Group, Inc (MDXG)
- Capricor Therapeutics, Inc. CAPR 9.04 +5.12%
- MiMedx Group, Inc MDXG 3.31 +0.91%
Capricor Therapeutics, Inc. and MiMedx Group, Inc are both Biotechnology companies. Capricor Therapeutics, Inc. and MiMedx Group, Inc are of similar size ($500.0M and $478.6M). Capricor Therapeutics, Inc. grew revenue faster over the last twelve months: −11.6% against −22.8%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −6.32%) and the lower return on invested capital (−1,019.7% vs −17.4%). Across the 18 metrics below, Capricor Therapeutics, Inc. leads on 9 and MiMedx Group, Inc on 9.
Valuation
Profitability
| Metric | CAPR | MDXG | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 77.29% | 68.51% |
| Operating margin | 0.00% | (8.28%) | 0.00% |
| Net margin | 0.00% | (6.32%) | 0.00% |
| Free cash flow margin | 0.00% | 6.26% | 0.00% |
| Return on equity | (73.70%) | (8.53%) | (51.96%) |
| Return on assets | (51.53%) | (6.58%) | (46.06%) |
| Return on invested capital | (1,019.73%) | (17.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack